Topics

Prestigious United Kingdom Based Media Company Nominates Tauri-Gum for an Award in the Category of Best CBD Edibles

19:00 EST 26 Jan 2020 | Globe Newswire

Award Nomination in Connection with a Major Upcoming European Industry Event

NEW YORK, NY, Jan. 27, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced that a prestigious United Kingdom (“UK”) based media company, nominated Tauri-Gum™ for an award in the category of Best CBD Edibles - - In connection with a major upcoming European industry event.  In addition, Tauriga has been invited, by UK based RASB Media, to operate a main floor corporate Exhibitor Booth at the upcoming “The CBD Show” on May 1-3, 2020 in Olympia, London, UK. Tauriga’s Chief Executive Officer, Mr. Seth M. Shaw, will be a keynote speaker at The CBD Show (Link: https://rasbmedia.com/team/seth-m-shaw/).

Below Link to The CBD Show (London, UK - - May 1-3, 2020):
Link:  https://rasbmedia.com/cbd-show/

The International CBD Show Expo (“The CBD Show”), held in London, will feature 5,000 B2B, B2C, B2G, aspiring business owners, retailers, e-tail, industry professionals, distributors, wholesalers, online resellers, investors, and pharmacists; will visit the first two days and the third day (May 3, 2020) is dedicated to the public sector for free!

There are many reasons to attend, above all around 100 Suppliers and over 50 high profile speakers, all in one room. For instance, expect to see industries such as beauty care, nutraceuticals, specialty beverage, functional food sector, cultivators, law, packaging firms, accounting, branding experts, private label, white label as well as pharmaceutical therapeutics. This is a professional event for professionals.

Gain insight into the CBD industry through product demonstrations, educational seminars and keynote presentations from companies such as CBD edibles, CBD topicals, CBD lifestyle products, CBD beauty, CBD vape, CBD tincture, CBD Cosmetics, and everything in-between. If you’re a B2B or B2C company and interested to find more about packaging, distributors, cultivators, investors, branding, private label, white label, law, accounting and everything in-between our event is the only event to look at.  Our event is a 3-day event. Two days for business and one day for public access. 

ABOUT TAURIGA SCIENCES, INC.

Tauriga Sciences, Inc. (TAUG) is a revenue generating company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities. One such opportunity on which the Company has acted, involves the Company having entered into the cannabidiol (or “CBD”) infused chewing gum product business, as more fully described above and in prior press releases.  This CBD infused chewing gum product has been branded under the following name: Tauri-Gum™.  The Company is currently in production of three distinct flavors of Tauri-Gum™: MINT, BLOOD ORANGE, and POMEGRANATE.  On December 6, 2019, the Company announced that it completed the initial production run (thereby expanding its existing product lines) with the introduction of a 25mg Vegan CBD Isolate Infused vegan gummy (“gumdrop”), branded under the name: Tauri-Gummies™. Further, the Company continues to identify and evaluate additional potential opportunities to generate revenue, as well as shareholder value, and leverage its resources and expertise to build a diversified and sustainable business model. Please visit our corporate website at www.tauriga.com.

The Company has also announced the development of a Cannabigerol (“CBG”) Isolate infused version of Tauri-Gum™.  The flavor that has been selected is Starfruit/Peach and each piece of gum will contain 10mg of CBG Isolate / Each blister pack will contain 80mg of CBG Isolate.  The Company expects to commence production during its 4th Fiscal Quarter of 2020 (January 1, 2020 – March 31, 2020).

In addition, on March 11, 2019, the Company announced the official launch of its E-Commerce site - as part of its Tauri-Gum™ commercialization strategy.  This site can be accessed by visiting the following URL address:  www.taurigum.com

The Company has established corporate offices in both New York City (USA) and Barcelona (Spain). 

DISCLAIMER -- Forward-Looking Statements

This press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in  forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements.

Attachment

CONTACT INFORMATION

Tauriga Sciences, Inc.
555 Madison Avenue, 5th Floor
New York, NY 10022
Chief Executive Officer
Mr. Seth M. Shaw
Email:  sshaw@tauriga.com
cell # (917) 796 9926
Corp. Website: www.tauriga.com
E-Commerce Website: www.taurigum.com 

Primary Logo

Tauriga Sciences, Inc.

Above Image Depicts Tauriga Sciences Inc.’s Logo with Embedded UK Flag
NEXT ARTICLE

More From BioPortfolio on "Prestigious United Kingdom Based Media Company Nominates Tauri-Gum for an Award in the Category of Best CBD Edibles "

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...